The latest cancer drugs news
Browsing: Cancer Drug News
QBiotics announces clinical collaboration with MSD targeting unresectable melanoma
QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals,…
Aspirin may accelerate progression of advanced cancers in older adults
Results from a recent clinical trial indicate that for older adults with advanced cancer, initiating…
IASLC WCLC 2020: Phase 3 eXalt3 study shows significantly longer progression-free survival in patients with ALK lung cancer
Patients with non-small cell lung cancer (NSCLC) carrying anaplastic lymphoma kinase (ALK) gene alterations who…
FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma
The Food and Drug Administration (FDA) approved belantamab mafodotin-blmf for adult patients with relapsed or…
Scientists discover novel drug target for pancreatic cancer
Scientists at Sanford Burnham Prebys Medical Discovery Institute, USA, have uncovered a novel drug target,…
Immune cell steroids help tumours suppress the immune system, offering new drug targets
A new study has revealed that tumours can evade the immune system by telling immune…
Precision medicine identifies key recurring mutation in head and neck cancers
Head and neck cancer is one of the leading causes of cancer-related deaths worldwide, and…
Adverse effects from cancer drug trials explained
A team of Norwegian researchers investigating how a certain type of drugs can kill cells…
New drug targets for lethal brain cancer discovered
More than 200 genes with novel and known roles in glioblastoma – the most aggressive…
A never-before-seen cell state may explain cancer’s ability to resist drugs
Cancer’s knack for developing resistance to chemotherapy has long been a major obstacle to achieving…